KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $964 | -12.8% | 5,700 | +11.8% | 0.01% | -16.7% |
| Q2 2023 | $1,106 | +60.3% | 5,100 | +34.2% | 0.01% | +50.0% |
| Q1 2023 | $690 | -7.6% | 3,800 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $747 | -99.9% | 3,800 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $855,000 | +98.8% | 3,800 | +11.8% | 0.01% | +100.0% |
| Q2 2022 | $430,000 | -0.2% | 3,400 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $431,000 | -37.9% | 3,400 | -35.8% | 0.00% | -33.3% |
| Q4 2021 | $694,000 | +1.3% | 5,300 | -5.4% | 0.00% | -25.0% |
| Q3 2021 | $685,000 | +39.8% | 5,600 | +30.2% | 0.00% | +33.3% |
| Q2 2021 | $490,000 | +10.1% | 4,300 | +16.2% | 0.00% | 0.0% |
| Q1 2021 | $445,000 | +18.4% | 3,700 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $376,000 | -23.3% | 3,700 | -15.9% | 0.00% | 0.0% |
| Q2 2020 | $490,000 | – | 4,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |